OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of Alzheimer’s Disease
Agueda Rostagno
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 107-107
Open Access | Times Cited: 158

Showing 1-25 of 158 citing articles:

The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow, Jeffrey M. Burns, Shaharyar M. Khan
Journal of Alzheimer s Disease (2010) Vol. 20, Iss. s2, pp. S265-S279
Open Access | Times Cited: 504

Drug repositioning: Progress and challenges in drug discovery for various diseases
Yi Hua, Xiaowen Dai, Yuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114239-114239
Open Access | Times Cited: 115

MicroRNA expression in extracellular vesicles as a novel blood‐based biomarker for Alzheimer's disease
Ashish Kumar, Yixin Su, Mitu Sharma, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4952-4966
Open Access | Times Cited: 39

Aerobic exercise attenuates LPS-induced cognitive dysfunction by reducing oxidative stress, glial activation, and neuroinflammation
Jae-Won Choi, Sang-Woo Jo, DaeEun Kim, et al.
Redox Biology (2024) Vol. 71, pp. 103101-103101
Open Access | Times Cited: 32

Trace Elements in Alzheimer’s Disease and Dementia: The Current State of Knowledge
Magdalena Tyczyńska, Marta Gędek, Adam Brachet, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2381-2381
Open Access | Times Cited: 16

Mitochondrial disorders leading to Alzheimer’s disease—perspectives of diagnosis and treatment
Magdalena Pszczołowska, Kamil Walczak, Weronika Miśków, et al.
GeroScience (2024) Vol. 46, Iss. 3, pp. 2977-2988
Open Access | Times Cited: 14

SMOC2 promotes microglia activity and neuroinflammation in Alzheimer's disease
Tianchi Wan, Chunkai Wang
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1

Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Seetha Harilal, Jobin Jose, Della Grace Thomas Parambi, et al.
Journal of Pharmacy and Pharmacology (2019) Vol. 71, Iss. 9, pp. 1370-1383
Open Access | Times Cited: 136

Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer’s Disease
P. Hemachandra Reddy, Maria Mańczak, Xiangling Yin
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 1, pp. 147-162
Open Access | Times Cited: 90

Advancements in the development of multi-target directed ligands for the treatment of Alzheimer’s disease
Naveen Kumar, Vijay Kumar, Piyush Anand, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 61, pp. 116742-116742
Closed Access | Times Cited: 66

ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries
Bowen Jia, Jing Li, Yiting Song, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10021-10021
Open Access | Times Cited: 36

Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 28

Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
Mohamed S. Attia, Ahmed Saeed Yahya, Nada Abdel Monaem, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 3, pp. 417-432
Open Access | Times Cited: 24

The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer’s and Parkinson’s Diseases
Witold Czarnik, Piotr Fularski, Agata Gajewska, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 308-308
Open Access | Times Cited: 13

Therapeutic Potential of Natural Compounds from Herbs and Nutraceuticals in Alleviating Neurological Disorders: Targeting the Wnt Signaling Pathway
Lei Li, Lin Wang, Lijuan Zhang
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 5, pp. 2411-2433
Closed Access | Times Cited: 10

Small fibre neuropathy in Fabry disease: a human-derived neuronal in vitro disease model and pilot data
Thomas Klein, Julia Grüner, Maximilian Breyer, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 10

Nanozymes: Potential Therapies for Reactive Oxygen Species Overproduction and Inflammation in Ischemic Stroke and Traumatic Brain Injury
Yunfan Yang, Zi-Xiang Li, Xiaochong Fan, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16450-16467
Closed Access | Times Cited: 10

The potential roles of salivary biomarkers in neurodegenerative diseases
Lingling Jiao, Hui-Lin Dong, Meng-Meng Liu, et al.
Neurobiology of Disease (2024) Vol. 193, pp. 106442-106442
Open Access | Times Cited: 8

Memory circuits in dementia: The engram, hippocampal neurogenesis and Alzheimer’s disease
Orly Lazarov, Muskan Gupta, Pavan Kumar, et al.
Progress in Neurobiology (2024) Vol. 236, pp. 102601-102601
Open Access | Times Cited: 8

A mechanistic survey of Alzheimer's disease
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Biophysical Chemistry (2021) Vol. 281, pp. 106735-106735
Open Access | Times Cited: 45

The Ketogenic Diet and Alzheimer's Disease
Haley Hersant, George T. Grossberg
The journal of nutrition health & aging (2022) Vol. 26, Iss. 6, pp. 606-614
Closed Access | Times Cited: 30

A network pharmacology approach to reveal the key ingredients in Scrophulariae Radix (SR) and their effects against Alzheimer's disease
Yingying Shi, Zhongqiang Chen, Lixia Huang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24785-e24785
Open Access | Times Cited: 6

Understanding Alzheimer's Disease
Alexander Strofs
Journal of Student Research (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6

C/EBPβ: A transcription factor associated with the irreversible progression of Alzheimer's disease
Qing Yao, Chubing Long, Pengcheng Yi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top